CEUFX | CIGYX | CEUFX / CIGYX | |
Total Expense Ratio | 0.91 | 0.90 | 101% |
Annual Report Gross Expense Ratio | 0.91 | 0.94 | 97% |
Fund Existence | 23 years | 10 years | - |
Gain YTD | 15.242 | 10.714 | 142% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 132B | 110M | 120,000% |
Annual Yield % from dividends | 0.81 | 0.55 | 147% |
Returns for 1 year | 7.86 | 4.51 | 174% |
Returns for 3 years | 36.00 | 17.97 | 200% |
Returns for 5 years | 13.26 | -10.56 | -126% |
Returns for 10 years | 53.80 | 32.72 | 164% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
ADCT | 3.40 | 0.11 | +3.34% |
ADC Therapeutics SA | |||
BIRK | 50.62 | 0.97 | +1.95% |
Birkenstock Holding plc | |||
ACGLN | 17.89 | 0.10 | +0.56% |
Arch Capital Group Ltd | |||
CDLR | 20.41 | -0.08 | -0.39% |
Cadeler A/S American Depositary Share (each representing four (4) | |||
GROV | 1.54 | -0.01 | -0.65% |
Grove Collaborative Holdings |